The new ABUS (automated breast ultrasound) offerings expand the Chicago-based company’s breast imaging portfolio with solutions designed to support supplemental screening for women with dense breasts, providing more flexible enterprise-wide exam review.
GE HealthCare said its new FDA-cleared solutions aim to help breast imaging programs standardize 3D ultrasound acquisition, support remote reading and simplify deployment across multi-site networks.
When used alongside mammography, Invenia ABUS Prime supports earlier cancer detection. GE HealthCare says it helps support standardized exams, more efficient workflows and operational consistency. It particularly achieves this in multi-site imaging environments.
Features include cSound Imageformer with AI-enabled tools. Among those, Scan Quality Assessment and Auto Nipple Detection (powered by Verisound AI) help deliver consistent, reproducible, high-quality scans and greater clinical confidence. The platform also offers a Fast Scan tool for increasing scan speed by up to 40% and a next-generation Reverse Curve transducer. AI-supported reading powered by QVCAD also streamlines review.
ABUS StreamVue, meanwhile, offers a zero-footprint, browser-based reading solution for standardizing ABUS exam review with remote access. The company collaborates with Candelis to deliver ABUS StreamVue in combination with Invenia ABUS Prime.
GE HealthCare said one of the first U.S. installations took place at BeSound in Los Angeles.
Commentary from GE HealthCare and BeSound officials
Karley Yoder, CEO, Ultrasound Solutions, Advanced Imaging Solutions, GE HealthCare, said:
“Invenia ABUS Prime builds on our commitment to advancing supplemental breast screening for women with dense breasts. As breast imaging networks look to scale across sites, Invenia ABUS Prime can help deliver streamlined workflows, reproducible imaging, with features designed to support both patient comfort and clinician efficiency.”
Russ Behler, global product director, LOGIQ Ultrasound, GE HealthCare, said:
“ABUS StreamVue extends the value of our ABUS platform with a flexible reading experience for enterprise imaging environments. This solution supports remote review, more standardized presentation, and simpler deployment across care settings.”
Bailey Renger, founder and CEO, BeSound, said:
“At BeSound, our mission is to make supplemental breast screening more accessible and more convenient for the women who need it. With Invenia ABUS Prime, we hope to expand access to advanced breast imaging in a way that is patient-centered and meets women where they are.”
